Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

This study has been withdrawn prior to enrollment.
(Study was not initiated)
Sponsor:
Information provided by:
Wockhardt
ClinicalTrials.gov Identifier:
NCT01399255
First received: July 19, 2011
Last updated: January 24, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)